A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies

Car t cell immunotherapy for human cancer

June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207 · see citing works

Adoptive cell transfer as personalized immunotherapy for human cancer

Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,492 · see citing works

Verification and validation of simulation models

Sargent, R. G. (2012) · Journal of Simulation · doi:10.1057/jos.2012.20 · Cited by 1,747 · see citing works

Global Manufacturing of CAR T Cell Therapy

Levine, B. L., Miskin, J., Wonnacott, K., & Keir, C. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.006 · Cited by 765 · see citing works

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease

Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., Zenzo, G. D., Lanzavecchia, A., Seykora, J. T., Cotsarelis, G., et al. (2016) · Science · doi:10.1126/science.aaf6756 · Cited by 742 · see citing works

Gene therapy in a patient with sickle cell disease

Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609677 · Cited by 696 · see citing works

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684 · see citing works

Verification of Computer Simulation Models

Naylor, T. H., & Finger, J. M. (1967) · Management Science · doi:10.1287/mnsc.14.2.b92 · Cited by 428 · see citing works

TREG-cell therapies for autoimmune rheumatic diseases

Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214 · see citing works

Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies

Simaria, A. S., Hassan, S., Varadaraju, H., Rowley, J., Warren, K., Vanek, P., & Farid, S. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25008 · Cited by 200 · see citing works

Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods

Harrison, R. P., Zylberberg, E., Ellison, S., & Levine, B. L. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.01.003 · Cited by 90 · see citing works

Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs

Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H.-D., & Reinke, P. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.09.006 · Cited by 86 · see citing works

Centralised versus decentralised manufacturing and the delivery of healthcare products: a United Kingdom exemplar

Harrison, R. P., Rafiq, Q. A., & Medcalf, N. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.05.003 · Cited by 40 · see citing works

Cost-effective bioprocess design for the manufacture of allogeneic CAR-T cell therapies using a decisional tool with multi-attribute decision-making analysis

Jenkins, M. J., & Farid, S. S. (2018) · Biochemical Engineering Journal · doi:10.1016/j.bej.2018.05.014 · Cited by 36 · see citing works

Autologous cell therapy: current treatments and future prospects .

Kazmi, B., Inglefield, C. J., & Lewis, M. P. (2009) · PubMed · Cited by 25 · see citing works

Untitled work

(2018) · PubMed · Cited by 14 · see citing works

Stem Cells and Cell Therapy

Bartel, R. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410396-2.00008-6 · Cited by 6 · see citing works

Navigating the Manufacturing Process and Ensuring the Quality of Regenerative Medicine Therapies

Medicine, F. O. R., Board on Health Sciences Policy, Division, H. A. M., & National Academies of Sciences, E. (2017) · National Academies Press eBooks · doi:10.17226/24913 · Cited by 5 · see citing works

Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Abou-el-Enein, M., Elsallab, M., Feldman, S. A., Fesnak, A. D., Heslop, H. E., Marks, P., Till, B. G., Bauer, G., & Savoldo, B. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0084 · Cited by 321 · see citing works

CAR-T cells: Early successes in blood cancer and challenges in solid tumors

Dana, H., Chalbatani, G. M., Jalali, S. A., Mirzaei, H. R., Grupp, S. A., Suarez, E. R., Rapôso, C., & Webster, T. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.020 · Cited by 95 · see citing works

Expanding access to CAR T cell therapies through local manufacturing

Elsallab, M., & Maus, M. V. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01981-8 · Cited by 72 · see citing works

Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression

Mueller, K. P., Piscopo, N. J., Forsberg, M. H., Saraspe, L. A., Das, A., Russell, B. E., Smerchansky, M. E., Cappabianca, D., Shi, L., Shankar, K., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004446 · Cited by 61 · see citing works

Optimization of CAR T-cell therapies supply chains

Karakostas, P., Panoskaltsis, N., Mantalaris, A., & Georgiadis, M. C. (2020) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2020.106913 · Cited by 35 · see citing works

Shipping and Logistics Considerations for Regenerative Medicine Therapies

Criswell, T. L., Swart, C., Stoudemire, J., Brockbank, K. G. M., Floren, M. L., Eaker, S. S., & Hunsberger, J. G. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab025 · Cited by 25 · see citing works

Interfacing data science with cell therapy manufacturing: where we are and where we need to be

Wang, B., Chen, R. Q., Li, J., & Roy, K. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.03.011 · Cited by 24 · see citing works

Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells

Floy, M. E., Shabnam, F., Simmons, A. D., Bhute, V. J., Jin, G., Friedrich, W. A., Steinberg, A. B., & Palecek, S. P. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-033922 · Cited by 16 · see citing works

Development of a robotic cluster for automated and scalable cell therapy manufacturing

Melocchi, A., Schmittlein, B., Jones, A. L., Ainane, Y., Rizvi, A., Chan, D., Dickey, E., Pool, K., Harsono, K., Szymkiewicz, D., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.03.010 · Cited by 15 · see citing works

Introducing Mobile Collaborative Robots into Bioprocessing Environments: Personalised Drug Manufacturing and Environmental Monitoring

Mathew, R., McGee, R., Roche, K. J., Warreth, S., & Papakostas, N. (2022) · Applied Sciences · doi:10.3390/app122110895 · Cited by 12 · see citing works

Simulation in healthcare supply chains with perishable products: a scoping review

Alidoost, F., Mustafee, N., Monks, T., & Harper, A. L. (2025) · Journal of the Operational Research Society · doi:10.1080/01605682.2025.2509698 · Cited by 11 · see citing works

An Integrated System Dynamics and Discrete Event Supply Chain Simulation Framework for Supply Chain Resilience with Non-Stationary Pandemic Demand

Camur, M. C., Thanos, A. E., Yund, W., Tseng, C.-Y., White, C. C., & Iakovou, E. T. (2023) · Winter Simulation Conference · doi:10.1109/wsc60868.2023.10407779 · Cited by 10 · see citing works

Spatiotemporal Readiness is Key to Preparing Regenerative Medicine for the Clinic

Stephens, N., Morrison, M. C., Martin, P. A., & Hogle, L. F. (2021) · Regenerative Medicine · doi:10.2217/rme-2020-0164 · Cited by 10 · see citing works

Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR‐T Therapy

Bequette, B. W. (2026) · Engineering in Life Sciences · doi:10.1002/elsc.70067 · Cited by 6 · see citing works

A simulation-based comparison of centralized and point-of-care supply chain strategies for autologous cell therapy

Wang, K., Tseng, C.-Y., Li, Z., White, C., Wang, B., Levine, B. L., & Fesnak, A. D. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.08.007 · Cited by 6 · see citing works

Capacity planning in a decentralized autologous cell therapy manufacturing network for low-cost resilience

Li, J., & White, C. C. (2022) · Flexible Services and Manufacturing Journal · doi:10.1007/s10696-022-09475-6 · Cited by 6 · see citing works

Advancing autologous CAR T-cell therapy through real-time patient health data integration: a simulation-based approach

Tseng, C.-Y., Wang, K., Lin, L., Zhang, C., White, C. C., & Wang, B. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.001 · Cited by 4 · see citing works

Single-cell technologies to dissect heterogenous immune cell therapy products

Mueller, K. P., & Saha, K. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100343 · Cited by 4 · see citing works

Building better CAR-T therapies

King, A. (2020) · Nature · doi:10.1038/d41586-020-02675-w · Cited by 3 · see citing works

Cooperation and competition of stem cell supply chain under government intervention: A case study

Sardashti, T., Yaghoubi, S., & Ghozatfar, A. (2025) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2025.109275 · Cited by 2 · see citing works

Integrating United States Biomanufacturing Across Vaccines and Therapeutics

Saha, K., & Roy, K. (2021) · NAM Perspectives · doi:10.31478/202104e · Cited by 2 · see citing works

Commercial autologous cell therapy: The value of real-time patient and therapy data

Wang, K., Levine, A. D., Levine, B. L., Wang, B., & White, C. (2022) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2022.100389 · Cited by 2 · see citing works

Impact of Fast-Track Regulatory Designations on Strategic Commercialization Decisions for Autologous Cell Therapies

Lam, C., Meinert, E., Yang, A., & Cui, Z. (2022) · Regenerative Medicine · doi:10.2217/rme-2021-0061 · Cited by 2 · see citing works

Cost-effectiveness analysis in the manufacture of allogeneic human induced pluripotent cells in Japan by agent-based modeling

Hayashi, Y., Oishi, K., & Sugiyama, H. (2022) · Process Safety and Environmental Protection · doi:10.1016/j.cherd.2022.03.038 · Cited by 1 · see citing works

Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Abou‐El‐Enein, M., Elsallab, M., Feldman, S. A., Fesnak, A. D., Heslop, H. E., Marks, P. W., Till, B. G., Bauer, G., & Savoldo, B. (2023) · doi:10.1158/2643-3230.c.6550449

The Science of CAR ‐T Cell Technology

Godby, R. C., Bock, A. M., Kenderian, S. S., & Lin, Y. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch20

Simulation-Based Optimization for Car T-Cell Therapy Logistics

Sadeghi, N., & Dehghanimohammadabadi, M. (2025) · Winter Simulation Conference · doi:10.1109/wsc68292.2025.11339116

Designing universal T cell therapies: strategies to evade natural killer cells

Bushara, O., Linette, G. P., & Carreno, B. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1826738

Optimizing CAR T-cell therapy manufacturing through lean inventory strategies: a resilience and cost-reduction analysis

Zeidan, K. A., Nehme, N., Refaat, M. M., & Kreidieh, F. (2026) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2026.2685693

A simulation-based comparison of centralized and point-of-care supply chain strategies for autologous cell therapy

Wang, K., Tseng, C.-Y., Li, Z., White, C., Wang, B., Levine, B. L., & Fesnak, A. D. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.08.007 · Cited by 6 · see citing works

Modeling of commercial autologous cell therapy manufacturing using simulation and optimization

Zhang, D. (2019)

Simulation-Based Decision Support System for Cell Therapy Manufacturing and Supply Chain

Liu, Y. (2021) · SMARTech Repository (Georgia Institute of Technology)

Supply chain management in regenerative medicine manufacturing

Foley, L., Hicks, C., & O'Neill, P. (2011) · Newcastle University ePrints (Newcastle Univesity) · doi:10.25405/ncl.34152483

Advancing autologous CAR T-cell therapy through real-time patient health data integration: a simulation-based approach

Tseng, C.-Y., Wang, K., Lin, L., Zhang, C., White, C. C., & Wang, B. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.001 · Cited by 4 · see citing works